ICP devices measure the pressure within the cranium caused by accidents, injuries, and trauma. The ICP monitoring has post-operative and diagnostic importance in patients suffering from cranial damage caused due to stroke, hydrocephalus, or other reasons. ICP devices help surgeons save the lives of patients suffering from these injuries with the help of proper treatment and timely intervention. Generally, there are two types of ICP monitors: one provides ICP data, whereas the other is capable of concurrent cerebrospinal fluid drainage.
The intracranial pressure (ICP) monitoring devices market is segmented on the basis of type, application, end user, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report offers insights and in-depth analysis of the market, emphasizing on parameters such as market trends, technological advancements, and market dynamics, along with the competitive landscape analysis of the world's leading market players.
Intracranial pressure (ICP) monitoring is crucial in diagnosing and treating neurological diseases such as subarachnoid and intracerebral hemorrhage, ischemic stroke, hydrocephalus, and meningitis/encephalitis. Bleeding in the brain, tumor, stroke, aneurysm, high blood pressure, or brain infection can lead to fluctuations in intracranial pressure. High ICP can cause headaches, blurred vision, vomiting, and other serious complications such as seizures, neurological damage, and death.
According to the Global Stroke Fact Sheet 2022, there are over 7.6 million new ischemic stroke cases yearly, and over 62% of all incident strokes are ischemic strokes. Around 11% of all ischemic stroke cases occur in patients aged 15–49 years, and more than 58% occur in people under 70. Also, 55% of all ischemic stroke cases occur in women and 45% in men. Moreover, the factsheet has mentioned that 77 million people across the world have survived from ischemic stroke.
The growth of the intracranial pressure (ICP) monitoring devices market is prominently attributed to the increasing prevalence of brain aneurysms across the world and rising number of diagnostic and treatment procedures associated with the brain. According to data published by the Brain Aneurysm Foundation in February 2023, an estimated 6.7 million people in the US suffer from unruptured brain aneurysms, which accounts for around 1 in 50 people. Additionally, an estimated 500,000 deaths are caused due to brain aneurysms across the globe each year.
Thus, the increasing prevalence of neurological diseases drives the growth of the global intracranial pressure (ICP) monitoring devices market.
The intracranial pressure (ICP) monitoring devices market, by offering, the market is fragmented into products and systems, solutions and platforms, and services. The products and systems segment held the largest market share in 2022 and services is anticipated to register the highest CAGR during the forecast period.
The intracranial pressure (ICP) monitoring devices market, by type, the market is fragmented into invasive and non-invasive. The invasive segment held the largest market share in 2022 and non-invasive is anticipated to register the highest CAGR during the forecast period.
The intracranial pressure (ICP) monitoring devices market, by application, the market is fragmented into traumatic brain injury, Reye’s syndrome, non- traumatic bleeds, hydrocephalus, space-occupying lesions, cerebral oedema, and others. The traumatic brain injury segment held the largest market share in 2022 and hydrocephalus is anticipated to register the highest CAGR during the forecast period.
Product launches and mergers and acquisitions are among the highly adopted strategies by the global intracranial pressure (ICP) monitoring devices market players. A few of the recent key product developments are listed below:
The regional trends and factors influencing the Intracranial Pressure (ICP) Monitoring Devices Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Intracranial Pressure (ICP) Monitoring Devices Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 1.67 Billion |
| Market Size by 2028 | US$ 2.43 Billion |
| Global CAGR (2022 - 2028) | 6.5% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By Offering
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The Intracranial Pressure (ICP) Monitoring Devices Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Intracranial Pressure (ICP) Monitoring Devices Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
The global intracranial pressure monitoring devices market based on product & systems, is segmented into solutions & platforms, and services. The products & systems segment held the largest market share in 2022 and services is anticipated to register the highest CAGR of 8.3% during the forecast period.
The intracranial pressure monitoring devices market majorly consists of the players such as Natus Medical Inc; RAUMEDIC AG; Sophysa SA; Integra LifeSciences Holdings Corp; Medtronic Plc; Braincare Desenvolvimento e Inovacao Tecnologica SA; NovaSignal Corp; Digitimer Ltd; Longeviti Neuro Solutions LLC, and Spiegelberg GmbH & Co KG.
The factors that are driving and restraining factors that will affect the intracranial pressure monitoring devices market in the coming years. Factors such as increasing prevalence of neurological diseases and rising incidence of traumatic brain injuries (TBIs). However, limitations associated with ICP monitors are restricting the market growth.
Intracranial pressure (ICP) monitoring devices measure the pressure within the cranium caused by accidents, injuries, and trauma. The ICP monitoring has post-operative and diagnostic importance in patients suffering from cranial damage caused due to stroke, hydrocephalus, or other reasons. ICP devices help surgeons save the lives of patients suffering from these injuries with the help of proper treatment and timely intervention. Generally, there are two types of ICP monitors: one provides ICP data, whereas the other is capable of concurrent cerebrospinal fluid drainage.